Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation

The clinical development of the meningococcal vaccine, 4CMenB, included 2 doses in vaccine-naïve adolescents, which was considered unlikely to be cost-effective for implementation. Theoretically, priming with 4CMenB in early childhood might drive strong immune responses after only a single booster d...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Rollier, CS, Dold, C, Blackwell, L, Linder, A, Silva-Reyes, L, Clutterbuck, E, Davis, K, Ford, K, Liu, X, Holland, A, Chan, H, Harbinson, H, O'Connor, D, Borrow, R, Snape, MD, Pollard, AJ
التنسيق: Journal article
اللغة:English
منشور في: Elsevier 2022

مواد مشابهة

مواد مشابهة